Page last updated: 2024-10-24

chlorambucil and Anaphylaxis

chlorambucil has been researched along with Anaphylaxis in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Anaphylaxis: An acute hypersensitivity reaction due to exposure to a previously encountered ANTIGEN. The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aronson, SB1

Reviews

1 review available for chlorambucil and Anaphylaxis

ArticleYear
The uvea.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1969, Volume: 81, Issue:5

    Topics: Anaphylaxis; Animals; Azathioprine; Chlorambucil; Epidemiologic Methods; Humans; Methotrexate; Stero

1969